Skip to main content

Robert G. Finizio

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Robert G. Finizio

Robert G. Finizio is recorded as Board Member at ZyVersa Therapeutics, Inc. (ZVSA). ZyVersa Therapeutics, Inc. reported in an 8-K filed December 3, 2025 that Robert G. Finizio resigned as independent director, Chairman of the Compensation Committee, and member of the Audit Committee, effective December 2, 2025. ZyVersa Therapeutics, Inc. reported in an 8-K filed June 12, 2025 that Robert G. Finizio was appointed Class III director, effective June 11, 2025.

“On December 2, 2025, Robert G. Finizio notified the Board of Directors (the "Board") of ZyVersa Therapeutics, Inc. (the "Company") of his intention to resign from his Board positions as an independent director, Chairman of the Compensation Committee, and member of the Audit Committee.”
ZyVersa Therapeutics, Inc. Form 8-K, filed December 3, 2025 · Read the filing
“With respect to Proposal No. 1, stockholders elected the Class III director nominees (Stephen C. Glover and Robert G. Finizio), each to hold office for a term of three years and until a successor is duly elected and qualified.”
ZyVersa Therapeutics, Inc. Form 8-K, filed June 12, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at ZyVersa Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.